Covid-19 Research

Open Access
Letter to Editor

Use of Polio Vaccine Salk vs SARS- CoV-2E and HIV-1E 2, both as Therapeutic Drug and Effective Vaccine to Make Memory-Cells Able to Stop Reinfections Google Scholar

Read • Cite • Share — permanent Open Access hosting with DOI tracking

Raffaele Ansovini* and Leonardo Compagnucci

Volume1-Issue7
Dates: Received: 2020-11-16 | Accepted: 2020-11-17 | Published: 2020-11-18
Pages: 311-312

Abstract

Dr. Ansovini began studying viruses by focusing his attention on HIV-1. The main discovery he made is that this virus, so difficult to treat, can be classified as “electrical”: one of its functional proteins, i.e. “p. 24”, actually has an electrical value, in other words it has a charge, and therefore it is not allosterically neutral as proteins usually are.

FullText HTML FullText PDF DOI: 10.37871/jbres1160


Certificate of Publication




Copyright

© 2020 Ansovini R, et al. Distributed under Creative Commons CC-BY 4.0

How to cite this article

Ansovini R, Compagnucci L. Use of Polio Vaccine Salk vs SARS- CoV-2E and HIV-1E 2, both as Therapeutic Drug and Effective Vaccine to Make Memory-Cells Able to Stop Reinfections. J Biomed Res Environ Sci. 2020 Nov 18; 1(7): 311-312. doi: 10.37871/jbres1160, Article ID: jbres1160


Subject area(s)

References



Comments


Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rapid review, DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable